Clinical Trials Browser

Phase 2 × OTHER × Cell Count × Clear all

NCT07330050 2026-01-09

WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03003728 2020-07-10

2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)

Phase 2 Withdrawn

Multiple Myeloma

NCT01186809 2019-01-23

CIK2

Phase 2 Completed

74 enrolled 6 charts

Other hematologic neoplasm

Hematologic Neoplasms